"Use of Surrogate Markers and Algorithms to Identify High-Risk Patients and Optimize Outcomes" in our NASH/MASH session presented by Dr. Rohit Loomba Rohit Loomba is diving into how to enhance early detection, and tailor treatments more effectively! #LiverConnect #LiverTwitter

Kicking off the first AASLD-ESLC Global Outreach Liver Connect Program in Egypt with Norah Terrault, Jasmohan Bajaj Bilal Hameed, Nancy Reau, Dr. Keyur Patel,AASLD

Norah Terrault speaking at AASLD-ESLC Liver Connect meeting on bold national strategies to eliminate HCV. Congratulations Egypt as global efforts follows your lead. AASLD ACG American Gastroenterological Association (AGA)

Dr. Nancy Reau speaks to HBV-HDV confection -more progressive course. Never forget to test for HDV in HBsAg+ patients. Nancy Reau AASLD #escl

Dr. Keyur Patel reviews DILI: 1) anti-infective most common cause globally.; 2) 50% have acute hepatocellular injury of which 10% may succumb to death or transplant-stop culprit drugs early! AASLD Jasmohan Bajaj

Forget drugs…maybe changes in gut microbiota is all we need to diagnose and treat cirrhosis, hepatic encephalopathy and predict mortality! Provocative.Jasmohan Bajaj Bilal Hameed AASLD

Successful 1st AASLD connect meeting in Egypt with ESLC! Amazing program and partnership. AASLD Norah Terrault Manal Abdelmalek Jasmohan Bajaj Nancy Reau

It is with a heavy heart that we at the Fatty Liver Alliance share the news of the sudden passing of Dr. Stephen A. Harrison, a distinguished hepatologist and cherished colleague to so many, on April 23, 2024. Dr. Harrison was a towering figure in the medical community, renowned

The patient advocacy community is shocked and deeply saddened by the sudden loss Dr. Stephen Harrison. A visionary in hepatology, Dr. Harrison foresaw many critical advancements and led the groundbreaking clinical studies that delivered the first U.S. FDA approved treatment for

Sad to hear of Dr. Harrison’s passing. Had the honor of introducing him as emcee for Academic Debates at TLM 2023. He was an entertaining and gracious presence. Here he is laying down the law with esteemed judges ⁦Manal Abdelmalek⁩ ⁦Naga Chalasani⁩ ⁦Rotonya Carr⁩

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…

The liver community mourns the loss of Dr. Stephen Harrison, a friend and a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. We extend our deepest condolences to Dr. Harrison’s family and colleagues during this

Maru Rinella MD Aleksander Krag Juan Pablo (JP) Arab, MD  Phil Newsome Meena Bansal Jeffrey V. Lazarus Ramon Bataller Marco Arrese, MD Silvia Sookoian Yaron Rotman Beautiful tribute to an amazing man—RIP my friend-you will be dearly missed by all who were privileged to know you and work with you. Your legacy and impact on this world will be everlasting.

Elliot Tapper GUILD Conference Indeed—Elliot Tapper and GUILD Conference. Maui 2022. A breathtaking experience with memories that last a lifetime. Glad neither one of fell out of that little boat as we gazed out at nature’s magnificence!

Final results from the Phase 3 REGENERATE trial, presented today as a late-breaker poster (LBP-036) at #EASLCongress, demonstrated that #OCA 25 mg reduces histologic progression to cirrhosis in patients with pre-cirrhotic fibrosis due to #MASH. The study confirmed the

Registrations open! Link below. Do not miss this opportunity to learn how innovations are shaping the GI care of the future!!